The abrupt termination of critical USAID-funded clinical trials, with insufficient time to safeguard the welfare of people who are participating, is profoundly unethical and utterly inexcusable.

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...

Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a biopharmaceutical company with a market capitalization of $2.3 billion focused on developing peptide-based drugs, stands at a pivotal juncture in its ...

The following is a summary of “Individual mHLA-DR trajectories in the ICU as predictors of early infections following liver ...

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a ...

The following is a summary of “Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations,” published in the February 2025 issue of the International Journal of ...

Deployed in over 100 US healthcare systems, Abridge has landed one of the largest genAI fundings in healthcare to date.

Hand techniques in this time interval were compared in a recent clinical trial from Australia. [21] Midwives randomized 1,340 women to perineal massage with a water-soluble lubricant versus "usual ...

Conservative Judaism's flagship said the new meal option is an "obvious" response to over a year of post-Oct. 7 tension at the Ivy League campus. After six months of treatment and recovery, the ...

Objective This study aims to calculate the global warming potential, in carbon dioxide (CO 2) equivalent emissions, from all in-scope activities involved in phase 1, 2, 3 and 4 clinical trials ...